Author

J. P. S. Yeong

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Assay:organoid / primary culture· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

A. Larbi· 1 shared A. Singhal· 1 shared A. TAKANO· 1 shared A. Tay· 1 shared C. Antoine Dutertre· 1 shared C. J. Lim· 1 shared C. Tang· 1 shared C. Wong· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Larbi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintOct 23, 2020

Proliferative and quiescent human gastric cancer stem-like cells are associated with differential chemoresistance and patient mortality

K. S. Ang, H. K. Lee, M. Chevrier…·J. Chen

This study identifies two stem-like gastric cancer subpopulations with distinct chemoresistance and survival outcomes using scRNA-seq and organoid models.

DOI 10.1101/2020.10.23.351726

humanscRNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJul 9, 2019

Partial absence of PD-1 expression by tumor-specific CD8+ T cells in EBV-driven lymphoepithelioma-like carcinoma: a case report

Y. SIMONI, E. Becht, S. Li…·E. W. NEWELL

This study reports the absence of PD-1 expression on EBV-specific CD8+ T cells in LELC, suggesting anti-PD1/PD-L1 therapy may not be effective for this cancer type.

DOI 10.1101/696278

humanbulk RNA-seq

𝕏 PostBluesky